| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3619638
[patent_doc_number] => 05688688
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-11-18
[patent_title] => 'Vector for expression of a polypeptide in a mammalian cell'
[patent_app_type] => 1
[patent_app_number] => 8/288336
[patent_app_country] => US
[patent_app_date] => 1994-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 59
[patent_figures_cnt] => 62
[patent_no_of_words] => 41882
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/688/05688688.pdf
[firstpage_image] =>[orig_patent_app_number] => 288336
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/288336 | Vector for expression of a polypeptide in a mammalian cell | Aug 9, 1994 | Issued |
| 08/285880 | AUGMENTED WESTERN BLOT FORMAT AND IMMUNOASSAY FOR DETECTION OF VIRAL ANTIBODIES | Aug 3, 1994 | Abandoned |
| 08/282959 | NOVEL HEPATITIS C E1 AND E2 TRUNCATED POLYPEPTIDES AND METHODS OF OBTAINING THE SAME | Jul 28, 1994 | Abandoned |
Array
(
[id] => 3665363
[patent_doc_number] => 05599720
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-02-04
[patent_title] => 'Measurement of analyte concentration'
[patent_app_type] => 1
[patent_app_number] => 8/261757
[patent_app_country] => US
[patent_app_date] => 1994-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4946
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/599/05599720.pdf
[firstpage_image] =>[orig_patent_app_number] => 261757
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/261757 | Measurement of analyte concentration | Jun 16, 1994 | Issued |
Array
(
[id] => 3873200
[patent_doc_number] => 05747239
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-05
[patent_title] => 'Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and preventions thereof as vaccines'
[patent_app_type] => 1
[patent_app_number] => 8/262037
[patent_app_country] => US
[patent_app_date] => 1994-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 20249
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/747/05747239.pdf
[firstpage_image] =>[orig_patent_app_number] => 262037
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/262037 | Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and preventions thereof as vaccines | Jun 16, 1994 | Issued |
Array
(
[id] => 3820777
[patent_doc_number] => 05730985
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-24
[patent_title] => 'Immunogens for the production of cocaine-hydrolyzing catalytic antibodies'
[patent_app_type] => 1
[patent_app_number] => 8/259004
[patent_app_country] => US
[patent_app_date] => 1994-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 10
[patent_no_of_words] => 5799
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/730/05730985.pdf
[firstpage_image] =>[orig_patent_app_number] => 259004
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/259004 | Immunogens for the production of cocaine-hydrolyzing catalytic antibodies | Jun 12, 1994 | Issued |
Array
(
[id] => 3867036
[patent_doc_number] => 05837550
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-17
[patent_title] => 'Method for screening an expression cDNA clone bank for the detection of polynucleotides'
[patent_app_type] => 1
[patent_app_number] => 8/255127
[patent_app_country] => US
[patent_app_date] => 1994-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 13
[patent_no_of_words] => 11165
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/837/05837550.pdf
[firstpage_image] =>[orig_patent_app_number] => 255127
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/255127 | Method for screening an expression cDNA clone bank for the detection of polynucleotides | Jun 6, 1994 | Issued |
Array
(
[id] => 4345752
[patent_doc_number] => 06214539
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-10
[patent_title] => 'Synthetic antigen the detection of aids-related disease'
[patent_app_type] => 1
[patent_app_number] => 8/252987
[patent_app_country] => US
[patent_app_date] => 1994-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8200
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 335
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/214/06214539.pdf
[firstpage_image] =>[orig_patent_app_number] => 252987
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/252987 | Synthetic antigen the detection of aids-related disease | May 31, 1994 | Issued |
| 08/248791 | PEPTIDIC PHOSPHINYLOXYMETHYL KETONES AS INTERLEUKIN-1BETA-CONVERTING ENZYME INHIBITORS | May 24, 1994 | Abandoned |
| 08/246985 | NON-A/NON-B/NON-C/NON-D/NON-E HEPATITIS AGENTS AND MOLECULAR CLONING THEREOF | May 19, 1994 | Abandoned |
Array
(
[id] => 4194151
[patent_doc_number] => 06130314
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-10
[patent_title] => 'Synthetic antigen for the detection of AIDS-related disease'
[patent_app_type] => 1
[patent_app_number] => 8/245516
[patent_app_country] => US
[patent_app_date] => 1994-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8393
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/130/06130314.pdf
[firstpage_image] =>[orig_patent_app_number] => 245516
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/245516 | Synthetic antigen for the detection of AIDS-related disease | May 17, 1994 | Issued |
Array
(
[id] => 3823130
[patent_doc_number] => 05731142
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-24
[patent_title] => 'Assay for detecting infection by HTLV-III'
[patent_app_type] => 1
[patent_app_number] => 8/245077
[patent_app_country] => US
[patent_app_date] => 1994-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 35
[patent_no_of_words] => 2471
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/731/05731142.pdf
[firstpage_image] =>[orig_patent_app_number] => 245077
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/245077 | Assay for detecting infection by HTLV-III | May 16, 1994 | Issued |
Array
(
[id] => 3514329
[patent_doc_number] => 05576175
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-11-19
[patent_title] => 'Complex suitable for carrying out a method of purifying pre-S hepatitis B surface antigen'
[patent_app_type] => 1
[patent_app_number] => 8/238847
[patent_app_country] => US
[patent_app_date] => 1994-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4430
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/576/05576175.pdf
[firstpage_image] =>[orig_patent_app_number] => 238847
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/238847 | Complex suitable for carrying out a method of purifying pre-S hepatitis B surface antigen | May 5, 1994 | Issued |
| 08/236547 | TUMOR MARKER PROTEIN AND ANTIBODIES THERETO FOR CANCER RISK ASSESSMENT OR DIAGNOSIS | May 1, 1994 | Abandoned |
Array
(
[id] => 3768780
[patent_doc_number] => 05756312
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-26
[patent_title] => 'Immunoreactive polypeptide compositions'
[patent_app_type] => 1
[patent_app_number] => 8/231368
[patent_app_country] => US
[patent_app_date] => 1994-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 9
[patent_no_of_words] => 18041
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/756/05756312.pdf
[firstpage_image] =>[orig_patent_app_number] => 231368
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/231368 | Immunoreactive polypeptide compositions | Apr 18, 1994 | Issued |
Array
(
[id] => 3589061
[patent_doc_number] => 05567603
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-10-22
[patent_title] => 'HIV-3 retrovirus and its use'
[patent_app_type] => 1
[patent_app_number] => 8/228519
[patent_app_country] => US
[patent_app_date] => 1994-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 40
[patent_no_of_words] => 16474
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/567/05567603.pdf
[firstpage_image] =>[orig_patent_app_number] => 228519
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/228519 | HIV-3 retrovirus and its use | Apr 14, 1994 | Issued |
| 08/217524 | SOLID DOSE FORMS CONTAINING BISMUTH | Mar 23, 1994 | Abandoned |
Array
(
[id] => 3588450
[patent_doc_number] => 05585276
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-12-17
[patent_title] => 'Medium and method for blotting macromolecules'
[patent_app_type] => 1
[patent_app_number] => 8/216880
[patent_app_country] => US
[patent_app_date] => 1994-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4782
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/585/05585276.pdf
[firstpage_image] =>[orig_patent_app_number] => 216880
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/216880 | Medium and method for blotting macromolecules | Mar 22, 1994 | Issued |
| 08/203002 | METHOD TO REDUCE THE PHYSIOLOGIC EFFECTS OF DRUGS ON MAMMALS | Feb 27, 1994 | Abandoned |
| 08/197537 | RECOMBINANT PROTEINS WITH THE IMMUNOREACTIVITY OF HEPATITIS B VIRUS E ANTIGEN (HBEAG), A PROCESS FOR THE PREPARATION THEREOF AND THE USE THEREOF IN IMMUNOASSAYS AND VACCINES | Feb 16, 1994 | Abandoned |